Cresset Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $209K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $603K | Sell |
|
|||||
|
2024
Q3 | $552K | Buy |
|
|||||
|
2024
Q2 | $451K | Buy |
|
|||||
|
2024
Q1 | $296K | Buy |
|
|||||
|
2023
Q4 | $188K | Sell |
|
|||||
|
2023
Q3 | $188K | Buy |
|
|||||
|
2023
Q2 | $91.2K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $189K | Buy |
|
|||||
|
2022
Q3 | $164K | Buy |
|
|||||
|
2022
Q2 | $150K | Sell |
|
|||||
|
2022
Q1 | $202K | Sell |
|
|||||
|
2021
Q4 | $198K | Buy |
|
|||||
|
2021
Q3 | $232K | Buy |
|
|||||
|
2021
Q2 | $220K | Sell |
|
|||||
|
2021
Q1 | $260K | Buy |
|
|||||
|
2020
Q4 | $199K | Buy |
|
|||||
|
2020
Q3 | $181K | Hold |
|
|||||
|
2020
Q2 | $247K | Buy |
|
|||||
|
2020
Q1 | $167K | Buy |
|
|||||
|
2019
Q4 | $180K | Sell |
|
|||||
|
2019
Q3 | $130K | Buy |
|
|||||
|
2019
Q2 | $174K | Sell |
|
|||||
|
2019
Q1 | $303K | Buy |
|
|||||
|
2018
Q4 | $8K | Buy |
|